Cancer Type/Condition: Eye cancer, intraocular melanoma
Stage/Subtype: ciliary body and choroid melanoma, small size
Country: U.S.A.
Trial Type: Treatment
Trial Status: Active
1.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 07-06-040, FVF4384s, NCT00765921
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2011-0919, NCT01585194
|
|
3.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2011-01411, 10-053, CDR0000674866, N01CM00071, N01CM00100, N01CM00070, MSKCC-10053, 8443, NCT01143402
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: TS001RSUM, NCT01473004
|
|
5.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: BMS CA184-168, NCT01565837
|
|
6.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 to 70 Sponsor: NCI Protocol IDs: 130093, 13-C-0093, NCT01814046
|
|
7.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 13298, I4C-MC-JTBA, NCT01287546
|
|
8.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CASE1612, NCI-2012-02203, NCT01730157
|